# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-187189
Filing Date
2026-04-28
Accepted
2026-04-28 16:23:09
Documents
11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | whwk-20260428.htm iXBRL | DEFA14A | 22779
2 | GRAPHIC | img96983719_0.jpg | GRAPHIC | 851334
3 | GRAPHIC | img96983719_1.jpg | GRAPHIC | 557039
| Complete submission text file | 0001193125-26-187189.txt |  | 3247528

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | whwk-20260428.xsd | EX-101.SCH | 7423
14 | EXTRACTED XBRL INSTANCE DOCUMENT | whwk-20260428_htm.xml | XML | 1305

Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38560 | Film No.: 26908228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)